Home / Publication / Biopharmaceutics Data Management System for Anonymized Data Sharing and Curation: First Application with Orbito IMI Project

論文

Biopharmaceutics Data Management System for Anonymized Data Sharing and Curation: First Application with Orbito IMI Project

Author(s): Kristin Lacy-Jones, Philip Hayward, Steve Andrews, Ian Gledhill, Mark McAllister, Bertil Abrahamsson, Amin Rostami-Hodjegan, Xavier Pepin

Year: 2017年3月1日

How Model-informed drug development rescue projects from a risky situation

事例紹介

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

論文

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

ウェビナー

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

ウェビナー

Powered by Translations.com GlobalLink Web Software

Biopharmaceutics Data Management System for Anonymized Data Sharing and Curation: First Application with Orbito IMI Project

Biopharmaceutics Data Management System for Anonymized Data Sharing and Curation: First Application with Orbito IMI Project

How Model-informed drug development rescue projects from a risky situation

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

メルマガ登録

クイックアクセス

ソリューション

お問合せ

Biopharmaceutics Data Management System for Anonymized Data Sharing and Curation: First Application with Orbito IMI Project

How Model-informed drug development rescue projects from a risky situation​

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

メルマガ登録

クイックアクセス

ソリューション

お問合せ

How Model-informed drug development rescue projects from a risky situation